Fri, May 13, 2011
[ Fri, May 13th 2011 ]: Market Wire
International Stem Cell Corporation Announces Changes to Streamline Management Team
[ Fri, May 13th 2011 ]: Market Wire
Kindred Healthcare Announces Receipt of All Requi .. ls to Proceed with Acquisition of RehabCare Group
[ Fri, May 13th 2011 ]: Market Wire
NUVO RESEARCH COMPLETES ITS ACQUISITION OF ZARS PHARMA
[ Fri, May 13th 2011 ]: Market Wire
Dr. Reddya?s Q4 FY11 & FY11 Financial Results
[ Fri, May 13th 2011 ]: Market Wire
ZIOPHARM Oncology Files Investigational New Drug .. a Novel DNA-Based Oncology Therapeutic Candidate
[ Fri, May 13th 2011 ]: Market Wire
Medical Facilities Corporation Reports 2011 First Quarter Financial Results
Thu, May 12, 2011
[ Thu, May 12th 2011 ]: Market Wire
Electromed, Inc. Reports 2011 Third Quarter Results
[ Thu, May 12th 2011 ]: Market Wire
St. Jude Medical Announces Second Quarter Dividend
[ Thu, May 12th 2011 ]: Market Wire
Response Genetics, Inc. Reports First Quarter Financial Results and Operational Update
[ Thu, May 12th 2011 ]: Market Wire
International Stem Cell Corporation Launches New .. keting Campaign for Lifeline Skin CareTM Products
[ Thu, May 12th 2011 ]: Market Wire
Oncolytics Biotech® Inc. Announces First Quarter 2011 Results
[ Thu, May 12th 2011 ]: Market Wire
Medtronic to Release New Clinical Data on Unrivaled Portfolio of Interventional Devices at EuroPCR
[ Thu, May 12th 2011 ]: Market Wire
PolyMedix Presents Clinical and Pre-Clinical Data .. efensin-Mimetic Antibiotic at ECCMID 2011 Meeting
[ Thu, May 12th 2011 ]: Market Wire
Human Genome Sciences Appoints Allan Baxter, Ph.D., to Its Board of Directors
Wed, May 11, 2011
[ Wed, May 11th 2011 ]: Market Wire
Medtronic Board of Directors Announces Appointment of Omar Ishrak as Chairman and CEO
[ Wed, May 11th 2011 ]: Market Wire
Health Net of Oregon Re-Enters Medicare Supplement Market
[ Wed, May 11th 2011 ]: Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Nevada
[ Wed, May 11th 2011 ]: Market Wire
Oncolytics Biotech® Inc. Enters into Commercial Supply Agreement with SAFC®
[ Wed, May 11th 2011 ]: Market Wire
Medical Action Industries 4th Quarter and Year-End Earnings Call to Take Place on May 25, 2011
[ Wed, May 11th 2011 ]: Market Wire
Derma Sciences First Quarter Results Feature Posi .. s, Advanced Wound Care Product Sales up 57%, Tota
[ Wed, May 11th 2011 ]: Market Wire
OncoSec Announces Leadership Team Appointments
Tue, May 10, 2011
[ Tue, May 10th 2011 ]: Market Wire
Micromet Reports First Quarter 2011 Financial Results and Highlights Near-Term Milestones
[ Tue, May 10th 2011 ]: Market Wire
Pro-Pharmaceuticalsa? Presentation at Noble Finan .. venth Annual Equity Conference to Be Webcast Live
[ Tue, May 10th 2011 ]: Market Wire
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
[ Tue, May 10th 2011 ]: Market Wire
A Prevnar 13® da Pfizer atende a todos os objeti .. clnicos bsicos de Fase III em adultos na faixa et
[ Tue, May 10th 2011 ]: Market Wire
La vacuna Prevnar 13® de Pfizer satisface todas .. studio en dos ensayos centrales en Fase 3 en adul
[ Tue, May 10th 2011 ]: Market Wire
Mehrere Phase-III-Studien besttigen auf internati .. tatistisch signifikanten klinischen Nutzen der RE
[ Tue, May 10th 2011 ]: Market Wire
SuperGen to Present at Noble Financial Capital Markets Equity Conference on May 17th
Mon, May 9, 2011
[ Mon, May 09th 2011 ]: Market Wire
China Kanghui Holdings to Report First Quarter 2011 Financial Results on May 16, 2011
[ Mon, May 09th 2011 ]: Market Wire
MiMedx Group, Inc. to Present at the Noble Financ .. Capital Markets' Seventh Annual Equity Conference
[ Mon, May 09th 2011 ]: Market Wire
Health Net Receives Full URAC Reaccreditation
[ Mon, May 09th 2011 ]: Market Wire
Medical Facilities Corporation to Host 2011 Annual and Special Meeting of Securityholders
[ Mon, May 09th 2011 ]: Market Wire
TSO3 Announces the Appointment of a New CFO
[ Mon, May 09th 2011 ]: Market Wire
Illumina Reduces Price of Whole Human Genome Sequencing Through Illumina Genome Network
[ Mon, May 09th 2011 ]: Market Wire
Synergetics USA, Inc. to Hold Investor Meetings with Benchmark Company
Sun, May 8, 2011
[ Sun, May 08th 2011 ]: Market Wire
Biogen Idec e Swedish Orphan Biovitrum ricevono i .. o pediatrico di terapia a lungo termine per l'emo
[ Sun, May 08th 2011 ]: Market Wire
Biogen Idec and Swedish Orphan Biovitrum Receive .. iatric Plan for Long-Lasting Hemophilia B Therapy
[ Sun, May 08th 2011 ]: Market Wire
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
[ Sun, May 08th 2011 ]: Market Wire
Plusieurs ©tudes de Phase III confirment le b©n .. significatif d'un traitement continu avec REVLIMI
Sat, May 7, 2011
[ Sat, May 07th 2011 ]: Market Wire
Rotech Healthcare Reports First Quarter 2011 Financial Results
[ Sat, May 07th 2011 ]: Market Wire
PPDa?s Mike Wilkinson Appointed by Gov. Perdue to U.S.S. North Carolina Battleship Commission
[ Sat, May 07th 2011 ]: Market Wire
U.S. Physical Therapy to Present at the Tenth Annual JMP Securities Research Conference
[ Sat, May 07th 2011 ]: Market Wire
Intergroup-Phase-III-Studie (CALGB 100104) belegt .. ® als Dauertherapie fr Patienten mit multiplen M
Fri, May 6, 2011
[ Fri, May 06th 2011 ]: Market Wire
Aetna Wins Plain Language Award
[ Fri, May 06th 2011 ]: Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Kendle International, Inc.
[ Fri, May 06th 2011 ]: Market Wire
The Law Office of Abe Shainberg Launches an Inves .. es of Fiduciary Duty by the Board of Kendle Inter
[ Fri, May 06th 2011 ]: Market Wire
Acclaimed Plastic and Reconstructive Surgeon Dr. .. ors to Serve as Host of Inaugural Aesthetic Award
[ Fri, May 06th 2011 ]: Market Wire
Centric Health Enters into Agreement to Acquire LifeMark Health

Allos Therapeutics e Mundipharma annunciano una collaborazione strategica per FOLOTYN

WESTMINSTER, Colorado--([ BUSINESS WIRE ])--Allos Therapeutics, Inc. (NASDAQ : ALTH) e Mundipharma International Corporation Limited (Mundipharma) hanno annunciato congiuntamente questa™oggi di avere perfezionato un accordo di collaborazione strategica per lo sviluppo congiunto di FOLOTYN® (pralatrexate per iniezione).

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.